NDC 54092-063 – Agrylin

Anagrelide Hydrochloride Anhydrous .5 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC54092-063

Product details

Brand name
Agrylin
Generic name
anagrelide hydrochloride
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA020333
Marketed since
March 14, 1997
Listing expires
December 31, 2027
Pharmacologic class
Platelet-reducing Agent

Active ingredients

Uses, dosage, side effects and warnings for Agrylin →

Package NDC codes (1)

Package NDCDescriptionSince
54092-063-01100 CAPSULE in 1 BOTTLE (54092-063-01)Mar 14, 1997